Klick Health has announced the Grand Prize winner of the $1,000,000 Klick Prize, following the submission of several hundred AI ideas from employees for life sciences clients. The company shared…
Upbound Group, Inc. (NASDAQ: UPBD), a leader in accessible and inclusive financial products powered by technology and data, has announced a definitive agreement to acquire Brigit, a top financial health…
Lyra Health, a leader in Workforce Mental Health solutions for employers, today shared early insights from its 2025 Workforce Mental Health Trends Forecast. The fifth annual study found that 81%…
Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG), a biopharmaceutical company focused on developing innovative therapies for neurodegenerative disorders, today announced promising interim preclinical data supporting the ongoing development of ALPHA-1062…
SurgeonCheck has launched an innovative surgeon recommendation tool. By visiting www.surgeoncheck.com, patients can easily find personalized suggestions for top surgeons in their area, powered by an extensive analysis of clinical…
Swisslog Healthcare, a leader in robotic medication management solutions, has partnered with BD, a global medical technology company, to co-market an innovative solution for hospital pharmacies. This collaboration integrates Swisslog’s…
Merck (NYSE: MRK), known as MSD outside the United States and Canada, has presented promising results from its Phase 2 waveLINE-007 trial at the 66th American Society of Hematology (ASH)…
The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) will present new findings at the 66th American Society of Hematology (ASH) Annual Meeting in San Diego. The data demonstrates…
AstraZeneca has announced that its supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) has been accepted by the U.S. Food and Drug Administration (FDA) for Priority Review. This application aims…
Aaron Nagiel, MD, PhD, a leading pediatric retinal specialist at Children’s Hospital Los Angeles (CHLA), often hears stories from parents long after their child’s retinal gene therapy treatment. These heartfelt…
Pfizer Inc. (NYSE: PFE) is set to showcase significant advancements in its hematology and breast cancer portfolios at the upcoming American Society of Hematology (ASH) Annual Meeting & Exposition (December…
SOLVE FSHD, a venture philanthropy organization focused on accelerating new therapies for facioscapulohumeral muscular dystrophy (FSHD), is inviting innovators from around the globe to compete for the USD$10 million FSHD…